Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback